Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 May;40(5):628–633. doi: 10.1136/gut.40.5.628

Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

P E Watkins 1, B F Warren 1, S Stephens 1, P Ward 1, R Foulkes 1
PMCID: PMC1027166  PMID: 9203942

Abstract

BACKGROUND: The aetiology and pathophysiology of ulcerative colitis remains unclear; however, there is increasing recognition of the critical role of inflammatory cytokines in the pathogenesis of this disease. Among these, tumour necrosis factor alpha (TNF alpha) seems to play an important role. AIM: To study the effects of an engineered human monoclonal antibody to TNF alpha (CDP571) in the treatment of idiopathic ulcerative colitis in the cottontop tamarin. METHODS: Six cottontop tamarins with confirmed ulcerative colitis received repeated doses of CDP571. Progression of disease was assessed by measuring both body weight and rectal biopsy pathology. RESULTS: All animals showed a rapid improvement in clinical condition and rectal biopsy pathology that was maintained following completion of the therapy. CONCLUSION: These studies indicate the efficacy of selective antibody therapy to TNF alpha for the treatment of ulcerative colitis in a primate and suggest that similar therapy in human could be of value.

Full text

PDF
628

Images in this article

630Image
on p.630

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braegger C. P., Nicholls S., Murch S. H., Stephens S., MacDonald T. T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992 Jan 11;339(8785):89–91. doi: 10.1016/0140-6736(92)90999-j. [DOI] [PubMed] [Google Scholar]
  2. Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1105–1110. doi: 10.1016/s0140-6736(94)90628-9. [DOI] [PubMed] [Google Scholar]
  3. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Bijl H., Woody J. N. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1125–1127. doi: 10.1016/s0140-6736(94)90632-7. [DOI] [PubMed] [Google Scholar]
  4. Fisher C. J., Jr, Opal S. M., Dhainaut J. F., Stephens S., Zimmerman J. L., Nightingale P., Harris S. J., Schein R. M., Panacek E. A., Vincent J. L. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med. 1993 Mar;21(3):318–327. doi: 10.1097/00003246-199303000-00006. [DOI] [PubMed] [Google Scholar]
  5. Kirkwood J. K., Epstein M. A., Terlecki A. J. Factors influencing population growth of a colony of cotton-top tamarins. Lab Anim. 1983 Jan;17(1):35–41. doi: 10.1258/002367783781070867. [DOI] [PubMed] [Google Scholar]
  6. Kirkwood J. K., Epstein M. A., Terlecki A. J., Underwood S. J. Rearing a second generation of cotton-top tamarins (Saguinus oedipus oedipus) in captivity. Lab Anim. 1985 Oct;19(4):269–272. doi: 10.1258/002367785780887491. [DOI] [PubMed] [Google Scholar]
  7. Kirkwood J. K., Pearson G. R., Epstein M. A. Adenocarcinoma of the large bowel and colitis in captive cotton-top tamarins Saguinus o. oedipus. J Comp Pathol. 1986 Sep;96(5):507–515. doi: 10.1016/0021-9975(86)90071-x. [DOI] [PubMed] [Google Scholar]
  8. Madara J. L., Podolsky D. K., King N. W., Sehgal P. K., Moore R., Winter H. S. Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine. Gastroenterology. 1985 Jan;88(1 Pt 1):13–19. doi: 10.1016/s0016-5085(85)80126-8. [DOI] [PubMed] [Google Scholar]
  9. Maini R. N., Brennan F. M., Williams R., Chu C. Q., Cope A. P., Gibbons D., Elliott M., Feldmann M. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy. Clin Exp Rheumatol. 1993 Mar-Apr;11 (Suppl 8):S173–S175. [PubMed] [Google Scholar]
  10. Murch S. H., Braegger C. P., Walker-Smith J. A., MacDonald T. T. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993 Dec;34(12):1705–1709. doi: 10.1136/gut.34.12.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murch S. H., Lamkin V. A., Savage M. O., Walker-Smith J. A., MacDonald T. T. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991 Aug;32(8):913–917. doi: 10.1136/gut.32.8.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Podolsky D. K., Lobb R., King N., Benjamin C. D., Pepinsky B., Sehgal P., deBeaumont M. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest. 1993 Jul;92(1):372–380. doi: 10.1172/JCI116575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rankin E. C., Choy E. H., Kassimos D., Kingsley G. H., Sopwith A. M., Isenberg D. A., Panayi G. S. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol. 1995 Apr;34(4):334–342. doi: 10.1093/rheumatology/34.4.334. [DOI] [PubMed] [Google Scholar]
  14. Sanderson J. D., Moss M. T., Tizard M. L., Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut. 1992 Jul;33(7):890–896. doi: 10.1136/gut.33.7.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stephens S., Emtage S., Vetterlein O., Chaplin L., Bebbington C., Nesbitt A., Sopwith M., Athwal D., Novak C., Bodmer M. Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. Immunology. 1995 Aug;85(4):668–674. [PMC free article] [PubMed] [Google Scholar]
  16. Stephens S., Emtage S., Vetterlein O., Chaplin L., Bebbington C., Nesbitt A., Sopwith M., Athwal D., Novak C., Bodmer M. Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. Immunology. 1995 Aug;85(4):668–674. [PMC free article] [PubMed] [Google Scholar]
  17. Stevens C., Walz G., Singaram C., Lipman M. L., Zanker B., Muggia A., Antonioli D., Peppercorn M. A., Strom T. B. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 1992 Jun;37(6):818–826. doi: 10.1007/BF01300378. [DOI] [PubMed] [Google Scholar]
  18. Sun X., Caplan M. S., Liu Y., Hsueh W. Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production. Dig Dis Sci. 1995 Mar;40(3):495–502. doi: 10.1007/BF02064356. [DOI] [PubMed] [Google Scholar]
  19. Thompson N. P., Montgomery S. M., Pounder R. E., Wakefield A. J. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet. 1995 Apr 29;345(8957):1071–1074. doi: 10.1016/s0140-6736(95)90816-1. [DOI] [PubMed] [Google Scholar]
  20. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  21. Wakefield A. J., Pittilo R. M., Sim R., Cosby S. L., Stephenson J. R., Dhillon A. P., Pounder R. E. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol. 1993 Apr;39(4):345–353. doi: 10.1002/jmv.1890390415. [DOI] [PubMed] [Google Scholar]
  22. Warren B. F., Watkins P. E. Animal models of inflammatory bowel disease. J Pathol. 1994 Apr;172(4):313–316. doi: 10.1002/path.1711720405. [DOI] [PubMed] [Google Scholar]
  23. van Dullemen H. M., van Deventer S. J., Hommes D. W., Bijl H. A., Jansen J., Tytgat G. N., Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995 Jul;109(1):129–135. doi: 10.1016/0016-5085(95)90277-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES